University of Michigan scientists running a human trial of the first ever gene therapy treatment for pain relief say that the virus-based vector which triggers the expression of a naturally occurring opioid appears to provide substantial pain relief. Their study, published in the Annals of Neurology, used a novel human-grade vector agent known as NP2. […]
